Court Report - Part IIPatent Docs6773720 ('Mesalazine Controlled Release Oral Pharmaceutical Compositions,' issued August 10, 2004) following a Paragraph IV certification as part of Watson's filing of an ANDA to manufacture a generic version of Shire's Lialda® (mesalamine, .
Court Report - Part II - May 23, 2012 - JD Supra (press release)
Court Report - Part II - May 23, 2012JD Supra (press release)6773720 ('Mesalazine Controlled Release Oral Pharmaceutical Compositions,' issued August 10, 2004) following a Paragraph IV certification as part of Watson's filing of an ANDA to manufacture a generic version of Shire's Lialda® (mesalamine, .
Name: Please send me a copy Message: - Proactive Investors UK
Name: Please send me a copy Message:Proactive Investors UK(Sources) Watson Pharmaceuticals – Co.